[Federal Register Volume 60, Number 98 (Monday, May 22, 1995)]
[Notices]
[Page 27115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-12402]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Ad Hoc Review Committee for the Recombinant DNA Advisory 
Committee; Notice of Meeting

    Notice is hereby given of a meeting of the Ad Hoc Review Committee 
for the Recombinant DNA Advisory Committee on June 19, 1995, at the 
National Institutes of Health, Building 31C, 6th Floor, Conference Room 
8, 9000 Rockville Pike, Bethesda, Maryland 20892, starting at 
approximately 9 a.m. to adjournment at approximately 5 p.m. The meeting 
will be open to the public to discuss three major topics for review: 
(1) Domain and mandate of the Recombinant DNA Advisory Committee; (2) 
composition of the Recombinant DNA Advisory Committee; and (3) 
Recombinant DNA Advisory Committee's review of human gene transfer 
protocols. Attendance by the public will be limited to space available. 
Members of the public wishing to speak at this meeting may be given 
such opportunity at the discretion of the Chair.
    Dr. Nelson A. Wivel, Director, Office of Recombinant DNA 
Activities, Suite 323, National Institutes of Health, 6006 Executive 
Boulevard, MSC 7052, Bethesda, Maryland 20892-7052, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at 
this meetings, roster of committee members and substantive program 
information. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should contact Dr. Wivel in advance of the meeting. A 
summary of the meeting will be available at a later date.
    OMB's ``Mandatory Information Requirements for Federal Assistance 
Program Announcements'' (45 FR 39592, June 11, 1980) requires a 
statement concerning the official government programs contained in the 
Catalog of Federal Domestic Assistance. Normally NIH lists in its 
announcements the number of title of affected individual programs for 
the guidance of the public. Because the guidance in this notice covers 
not only virtually every NIH program but also essentially every Federal 
research program in which DNA recombinant molecule techniques could be 
used, it has been determined not to be cost effective or in the public 
interest to attempt to list these programs. Such a list would likely 
require several additional pages. In addition, NIH could not be certain 
that every Federal program would be included as many Federal agencies, 
as well as private organizations, both national and international, have 
elected to follow the NIH Guidelines. In lieu of the individual program 
listing, NIH invites readers to direct questions to the information 
address above about whether individual programs listed in the Catalog 
of Federal Domestic Assistance are affected.

    Dated: May 15, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-12402 Filed 5-19-95; 8:45 am]
BILLING CODE 4140-01-M